4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000052
Director acquired 1,878 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Foster-Cheek Kaye I · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-29 | Exercise or conversion : show line 1 in the form | +1,878 | 5,478 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-28 | Grant or award : show line 2 in the form Stock options (right to buy) | +8,096 | 8,096 | D |
| 2020-05-28 | Grant or award : show line 3 in the form Restricted stock units | +1,686 | 1,686 | D |
| 2020-05-29 | Exercise or conversion : show line 4 in the form Restricted stock units | −1,878 | 0 | D |
Loading xslF345X03/wf-form4_159104599634402.xml…